CD274 and non-small cell lung carcinoma: With the same control group of PBC, results of indirect comparison indicated that PEM plus PBC significantly improved PFS by 49% and showed numerically better OS for patients with NSCLC with PD‐L1 TPS ≥50% than PEM alone.